Objectives. To assess the efficacy of Reslip (doxylamine) in acute insomnia in comparison with Donormyl. Materials and methods. A multicenter, open, randomized trial was conducted at six medical centers in the Russian Federation. The trial included 60 patients with acute insomnia aged 30–59 years, who were randomized into two groups. Patients of one group received Reslip and those of the other received Donormyl at the same dose and regime. Results. Most patients in both groups experienced improvements in the clinical signs of acute insomnia. The severity of insomnia, daytime drowsiness, and reductions in quality of sleep in both groups showed highly significant decreases. Side effects from the drugs were rare and in most cases did not require treatment termination. There were no significant differences in treatment results with Reslip and Donormyl. Conclusions. Short-term treatment with doxylamine formulations had marked positive clinical effects in acute insomnia, combined with satisfactory tolerance by the patients. The Russian doxylamine formulation Reslip had clinical efficacy and tolerance which were no different from those of Donormyl and can be used in clinical practice for the treatment of acute insomnia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. Ohayon, “Epidemiology of insomnia: what we know and what we still need to learn,” Sleep Med. Rev., 6, No. 2, 97–111 (2002), https://doi.org/10.1053/smrv.2002.0186.
A. V. Golenkov and M. G. Poluektov, “The prevalence of sleep disorders in the population of Chuvashia (results of a complete interview study)” Zh. Nevrol. Psikhiat., 111, No. 6, 64–67 (2011).
International Classification of Sleep Disorders, American Academy of Sleep Medicine Darien, IL (2014), 3rd ed.
J. Ellis, M. Perlis, L. Neale, C. Espie, and C. Bastien, “The natural history of insomnia: Focus on prevalence and incidence of acute insomnia,” J. Psychiatr. Res., 46, No. 10, 1278–1285 (2012), https://doi.org/10.1016/j.jpsychires.2012.07.001.
B. B. Brown and H. W. Werner, “The effects of decapryn succinate, a new antihistamine agent, in some natural and acquired hypersensitivities in animals; 2-[alpha-dimethylaminoethoxy)-alpha-methylbenzyl] pyridine succinate,” Ann. Allergy, 6, No. 2, 122–130 (1948).
Ya. I. Levin, and K. N. Strygin, “Donormyl in the treatment of insomnia,” Lech. Nerv. Bolez., 6, No. 2, 16 (2005).
J. Vande Griend and S. Anderson, “Histamine-1 receptor antagonism for treatment of insomnia,” J. Am. Pharm. Assoc., 52, No. 6, 210–219 (2012), https://doi.org/10.1331/JAPhA.2012.12051.
G. Smith and P. Smith, “Effects of doxylamine and acetaminophen on postoperative sleep,” Clin. Pharmacol. Ther., 37, No. 5, 549–557 (1985), https://doi.org/10.1038/clpt.1985.87.
A. A. Smirnov, A. V. Gustov, and O. Yu. Zheltova, “Efficacy of the use of Donormyl in the treatment of insomnias in patients with cerebral ischemia,” Zh. Nevrol. Psikhiat., 106, No. 3, 56–57 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 4, Iss. II, Sleep Disorder, pp. 56–59, April, 2017.
Rights and permissions
About this article
Cite this article
Mel’nikov, A.Y., Lavrik, S.Y., Bikbulatova, L.F. et al. Efficacy of Reslip (doxylamine) in Acute Insomnia: A Multicenter, Open, Comparative, Randomized Trial. Neurosci Behav Physi 49, 45–47 (2019). https://doi.org/10.1007/s11055-018-0689-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-018-0689-y